Davis; Peter David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Davis; Peter David.The latest application filed is for "method and composition for alleviating tumor symptoms".

Company Profile

0.19.14

Davis; Peter David - Watlington GB
Davis; Peter David - Oxford GB
Davis; Peter David - Oxfordshire GB
Davis, Peter David - Aston Rowant GB
Davis; Peter David - Letchworth GB2

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method and Composition for Alleviating Tumor Symptoms App 20150141349 - Davis; Peter David ; et al.	2015-05-21
Bioreductively-activated prodrugs App 20090202571 - Davis; Peter David ; et al.	2009-08-13
Bioreductively-Activated Prodrugs App 20080145372 - Davis; Peter David ; et al.	2008-06-19
Substituted stilbene compounds with vascular damaging activity Grant 7,265,136 - Davis September 4, 2	2007-09-04
Bioreductively-activated prodrugs App 20070099871 - Davis; Peter David ; et al.	2007-05-03
Divided dose therapies with vascular damaging activity App 20070021392 - Davis; Peter David	2007-01-25
Benzimidazole vascular damaging agents App 20060264492 - Davis; Peter David	2006-11-23
Bioreductively activated stilbene prodrugs App 20060223827 - Davis; Peter David ; et al.	2006-10-05
Compositions with vascular damaging activity Grant 7,105,501 - Davis September 12, 2	2006-09-12
Combinations for the treatment of diseases involving angiogenesis App 20060198846 - Davis; Peter David	2006-09-07
Combinations for the treatment of diseases involving angiogenesis Grant 7,087,627 - Davis August 8, 2	2006-08-08
Benzimidazole vascular damaging agents Grant 7,081,469 - Davis July 25, 2	2006-07-25
Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases Grant 7,012,076 - Moffat , et al. March 14, 2	2006-03-14
N-acetylcolchinol-O-phosphate combination therapies with vascular damaging activity Grant 6,906,048 - Davis , et al. June 14, 2	2005-06-14
N-acetylcolchinol-o-phosphate combination therapies with vascular damaging activity App 20050107346 - Davis, Peter David ; et al.	2005-05-19
Benzimidazole vascular damaging agents App 20040058972 - Davis, Peter David	2004-03-25
Benzimidazole vascular damaging agents Grant 6,645,950 - Davis November 11, 2	2003-11-11
Compositions with vascular damaging activity App 20030181424 - Davis, Peter David	2003-09-25
Combination therapies with vascular damaging activity App 20030166617 - Davis, Peter David ; et al.	2003-09-04
Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases App 20030153755 - Moffat, David Festus Charles ; et al.	2003-08-14
Fused polycyclic 2-aminopyrimidine derivatives Grant 6,599,908 - Davis , et al. July 29, 2	2003-07-29
2-pyrimidineamine derivatives and processes for their preparation Grant 6,552,029 - Davis , et al. April 22, 2	2003-04-22
Divided dose therapies with vascular damaging activity App 20030055024 - Davis, Peter David	2003-03-20
Substituted 2-anilinopyrimidines useful as protein kinase inhibitors Grant 6,337,335 - Hutchings , et al. January 8, 2	2002-01-08
Substituted 2-anilinopyrimidines useful as protein kinase inhibitors Grant 6,235,746 - Davis , et al. May 22, 2	2001-05-22
Fused polycyclic 2-aminopyrimidine derivatives Grant 6,133,257 - Batchelor , et al. October 17, 2	2000-10-17
2-Pyrimidineamine derivatives and processes for their preparation Grant 6,114,333 - Davis , et al. September 5, 2	2000-09-05
Substituted 2-pyrimidineamines and processes for their preparation Grant 6,093,716 - Davis , et al. July 25, 2	2000-07-25
Fused polycyclic 2-aminopyrimidine derivatives Grant 6,057,329 - Davis , et al. May 2, 2	2000-05-02
Substituted 2-anilinopryimidines useful as protein kinase inhibitors Grant 6,048,866 - Hutchings , et al. April 11, 2	2000-04-11
Substituted 2-anilinopyrimidines useful as protein kinase inhibitors Grant 5,958,935 - Davis , et al. September 28, 1	1999-09-28
5-aminopyrazoles useful as tyrosine kinase inhibitors Grant 5,922,741 - Davis , et al. July 13, 1	1999-07-13
4-[3-indolyl]-1H-pyrrolone Grant 5,721,245 - Davis , et al. February 24, 1	1998-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.